About March Biosciences
March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient care in the most challenging hematological malignancies. March Bio's lead asset is at the end of Phase I trials for T-cell malignancies, diseases with a dismal prognosis that is currently unaddressed by CAR-T and targeted therapy technologies. The company's pipeline is designed to expand on these early successes to more broadly impact other high-challenge cancers.
Founded in 2021 by Malcolm Brenner, Max Mamonkin and Sarah Hein.
- Founded
- 2021
- Employees
- 1 to 10
- Total funding
- $18.2M
- Headquarters
- Houston
Leadership
The top of March Biosciences's org chart, with how many people report into each leader.
Sarah Hein
Cofounder & CEO
14 reports
Max Mamonkin
Co-Founder and CSO
9 reports
Gurpreet Ratra
Chief Business Officer
Leah DiMascio
COO
Alice Bexon
Acting Chief Medical Officer
Dr Alice Bexon
Acting Chief Medical Officer
Jobs at March Biosciences
No open positions right now. Explore more companies on TheJobsMap.